Intrinsic Value of S&P & Nasdaq Contact Us

Virax Biolabs Group Limited VRAX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • GB • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.00
+567.6%

Virax Biolabs Group Limited (VRAX) has 12 identified peers for comparison in the Healthcare sector. Peers include ALLR, BDRX, BWV, CDIO, HILS, KPRX and others.

VRAX has a market capitalization of $650.43K, compared to an average peer market cap of $18.18M. VRAX is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message